Epigenetic regulatory mechanism of ADAMTS12 expression in osteoarthritis

Mol Med. 2023 Jul 3;29(1):86. doi: 10.1186/s10020-023-00661-2.

Abstract

Background: Osteoarthritis (OA) is a degenerative joint disease with lacking effective prevention targets. A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAMTS12) is a member of the ADAMTS family and is upregulated in OA pathologic tissues with no fully understood molecular mechanisms.

Methods: The anterior cruciate ligament transection (ACL-T) method was used to establish rat OA models, and interleukin-1 beta (IL-1β) was administered to induce rat chondrocyte inflammation. Cartilage damage was analyzed via hematoxylin-eosin, Periodic Acid-Schiff, safranin O-fast green, Osteoarthritis Research Society International score, and micro-computed tomography assays. Chondrocyte apoptosis was detected by flow cytometry and TdT dUTP nick-end labeling. Signal transducer and activator of transcription 1 (STAT1), ADAMTS12, and methyltransferase-like 3 (METTL3) levels were detected by immunohistochemistry, quantitative polymerase chain reaction (qPCR), western blot, or immunofluorescence assay. The binding ability was confirmed by chromatin immunoprecipitation-qPCR, electromobility shift assay, dual-luciferase reporter, or RNA immunoprecipitation (RIP) assay. The methylation level of STAT1 was analyzed by MeRIP-qPCR assay. STAT1 stability was investigated by actinomycin D assay.

Results: The STAT1 and ADAMTS12 expressions were significantly increased in the human and rat samples of cartilage injury, as well as in IL-1β-treated rat chondrocytes. STAT1 is bound to the promoter region of ADAMTS12 to activate its transcription. METTL3/ Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2BP2) mediated N6-methyladenosine modification of STAT1 promoted STAT1 mRNA stability, resulting in increased expression. ADAMTS12 expression was reduced and the IL-1β-induced inflammatory chondrocyte injury was attenuated by silencing METTL3. Additionally, knocking down METTL3 in ACL-T-produced OA rats reduced ADAMTS12 expression in their cartilage tissues, thereby alleviating cartilage damage.

Conclusion: METTL3/IGF2BP2 axis increases STAT1 stability and expression to promote OA progression by up-regulating ADAMTS12 expression.

Keywords: ADAMTS12; IGF2BP2; Inflammation; METTL3; Osteoarthritis; STAT1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAMTS Proteins / genetics
  • ADAMTS Proteins / metabolism
  • Animals
  • Apoptosis
  • Cartilage / metabolism
  • Cells, Cultured
  • Chondrocytes / metabolism
  • Humans
  • Interleukin-1beta / metabolism
  • Methyltransferases / metabolism
  • MicroRNAs* / metabolism
  • Osteoarthritis* / metabolism
  • RNA-Binding Proteins / metabolism
  • Rats
  • X-Ray Microtomography

Substances

  • Interleukin-1beta
  • MicroRNAs
  • ADAMTS12 protein, human
  • ADAMTS Proteins
  • METTL3 protein, human
  • Methyltransferases
  • IGF2BP2 protein, human
  • RNA-Binding Proteins